Pilot Study of Percutaneous Correction of Hallux Valgus

Last updated: March 26, 2025
Sponsor: Istituto Ortopedico Rizzoli
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bunion

Treatment

SERI osteotomy

percutaneous osteotomy according to Chevron

Clinical Study ID

NCT05880407
hallux valgus
  • Ages 18-65
  • All Genders

Study Summary

This is a pilot study with a randomized controlled design.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients of both sexes with adult hallux valgus with indication for correctivesurgical treatment

  • HVA (hallux valgus angle): 20°-40°

  • IMA (intermetatarsal angle): 10°-20°

Exclusion

Exclusion Criteria:

  • Patients with instability of the first metatarsophalangeal joint

  • Patients with severe morphostructural alterations or other pathologies in the footand lower limb

  • patients requiring additional surgical procedures

  • patients with severe vascular and neurological systemic pathologies

  • systemic pathologies that may impair bone consolidation

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: SERI osteotomy
Phase:
Study Start date:
February 22, 2022
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • Istituto Ortopedico Rizzoli

    Bologna, 40136
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.